partybarackisinthehousetonight:
damn girl are you internet explorer because you’re not responding
A study conducted by psychiatrist Charles Grob, a researcher at Harbor-UCLA Medical Center, administered psilocybin — an active component of psychedelic mushrooms — to cancer patients near the end-of-life to see if it could reduce their fear of death. The research, completed in 2008 and published in the Archives of General Psychiatry in 2011, showed that the psychedelic could, in fact, be administered safely and reduce the anxiety and depression associated with the end-of-life.
Grob is not alone in his interest in the relationship between psychedelics and death-related emotions. Dr. John Halpern, head of the Laboratory for Integrative Psychiatry at McLean Hospital in Belmont, Massachusetts, used MDMA (ecstasy) to quell the anxiety in two patients with Stage 4 cancer. Ongoing studies at New York University’s medical school and Johns Hopkins Bayview Medical Center are using psilocybin with terminally-ill patients.
Saturday Morning Breakfast Cereal by Zach Wiener [website]
[h/t: bluedogeyes]
